Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer
Open Access
- 25 November 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11), e0242544
- https://doi.org/10.1371/journal.pone.0242544
Abstract
Multidrug-resistant organisms (MDRO) are considered an emerging threat worldwide. Data covering the clinical impact of MDRO colonization in patients with solid malignancies, however, is widely missing. We sought to determine the impact of MDRO colonization in patients who have been diagnosed with Non-small cell lung cancer (NSCLC) who are at known high-risk for invasive infections. Patients who were screened for MDRO colonization within a 90-day period after NSCLC diagnosis of all stages were included in this single-center retrospective study. Two hundred and ninety-five patients were included of whom 24 patients (8.1%) were screened positive for MDRO colonization (MDROpos) at first diagnosis. Enterobacterales were by far the most frequent MDRO detected with a proportion of 79.2% (19/24). MDRO colonization was present across all disease stages and more present in patients with concomitant diabetes mellitus. Median overall survival was significantly inferior in the MDROpos study group with a median OS of 7.8 months (95% CI, 0.0–19.9 months) compared to a median OS of 23.9 months (95% CI, 17.6–30.1 months) in the MDROneg group in univariate (p = 0.036) and multivariate analysis (P = 0.02). Exploratory analyses suggest a higher rate of non-cancer-related-mortality in MDROpos patients compared to MDROneg patients (p = 0.002) with an increased rate of fatal infections in MDROpos patients (p = 0.0002). MDRO colonization is an independent risk factor for inferior OS in patients diagnosed with NSCLC due to a higher rate of fatal infections. Empirical antibiotic treatment approaches should cover formerly detected MDR commensals in cases of (suspected) invasive infections.This publication has 70 references indexed in Scilit:
- Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective studyBMC Infectious Diseases, 2013
- Frequent Combination of Antimicrobial Multiresistance and Extraintestinal Pathogenicity in Escherichia coli Isolates from Urban Rats (Rattus norvegicus) in Berlin, GermanyPLOS ONE, 2012
- COPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEuropean Respiratory Journal, 2009
- Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicityCurrent Opinion in Infectious Diseases, 2007
- Insertion Sequence–Driven Diversification Creates a Globally Dispersed Emerging Multiresistant Subspecies of E. faeciumPLoS Pathogens, 2007
- Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic ComplexEmerging Infectious Diseases, 2005
- Risk Factors for Development of Vancomycin‐Resistant Enterococcal Bloodstream Infection in Patients with Cancer Who Are Colonized with Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- The Pattern of Respiratory Infection in Patients with Lung Cancer.The Tohoku Journal of Experimental Medicine, 1994
- The impact of pulmonary infections on the survival of lung cancer patientsCancer, 1990